文献速递妇科肿瘤

PD-L1阳性铂类难治性宫颈癌的免疫检查点阻断治疗

Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma.
PubMed 文献 · J Clin Oncol · 2019-04-26

一例36岁女性PD-L1阳性铂类难治性宫颈癌患者,初诊为FIGO IB3期鳞癌,接受顺铂为基础的放化疗及近距离放疗后达完全临床缓解,14个月后出现盆腔复发及肺转移。本文属肿瘤学大查房系列,通过病例展示、诊断与管理挑战、相关文献回顾及作者建议的管理方法,帮助读者将关键研究结果应用于临床实践。

要点

  • 病例为36岁女性,初诊宫颈鳞癌FIGO IB3期,接受顺铂为基础的放化疗加近距离放疗后达完全临床缓解。
  • 14个月后出现盆腔复发伴肺转移,表现为严重盆腔及右侧胁腹痛、恶病质。
  • 本文为肿瘤学大查房系列,旨在结合病例与文献回顾,帮助读者将关键研究结果应用于临床实践。

核心结论

  • 本文通过一例PD-L1阳性铂类难治性宫颈癌病例,结合文献回顾及作者建议的管理方法,帮助读者将关键研究结果应用于临床实践。

研究设计与样本

  • 肿瘤学大查房系列文章,包含病例展示、诊断与管理挑战描述、相关文献回顾及作者建议的管理方法总结。

主要发现

  • 患者36岁女性,因间断出血、性交痛及盆腔痛就诊,宫颈被5 cm直径脆弱病灶替代,活检为低分化鳞状细胞癌。
  • 双合诊盆腔及直肠阴道检查及影像学检查符合国际妇产科联盟(FIGO)IB3期宫颈鳞状细胞癌。
  • 接受顺铂为基础的放化疗(顺铂40 mg/m2体表面积每周一次,计划总剂量50 Gy调强放疗)加高剂量率腔内近距离放疗(使A点总剂量达80至85 Gy)。
  • 尽管因交通问题缺席8次放疗,仍达完全临床缓解;14个月后出现严重盆腔及右侧胁腹痛,体检见固定质硬盆腔包块,CT引导下活检证实复发,分期扫描发现肺转移。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 36-year-old white married mother of two small children presented with intermenstrual bleeding, dyspareunia, and pelvic pain. Because of significant lapses in health care coverage, she had had only sporadic screening for cervical cancer over the past 15 years. On evaluation with a vaginal speculum, her cervix was found to have been replaced by a friable lesion 5 cm in diameter. Biopsy revealed poorly differentiated, squamous cell carcinoma. Bimanual pelvic and rectovaginal examination, as well as radiographic imaging studies, were consistent with an International Federation of Gynecology and Obstetrics (FIGO) stage IB3 squamous cell carcinoma of the cervix. She was treated with cisplatin-based chemoradiation (40 mg/m2 body surface area once per week with a planned total dose of 50 Gy using intensity modulated radiotherapy) plus high-dose-rate intracavitary brachytherapy (to bring the total dose to point A to 80 to 85 Gy). Despite missing eight radiotherapy sessions because of transportation issues, she had a complete clinical response. Fourteen months later, she developed severe pelvic and right flank pain. In the clinic, she was cachectic and reported significant abdominal discomfort that kept her from eating well over the past several months. She was no longer able to work as a medical assistant and spent most of her time confined to her apartment. Physical examination demonstrated a fixed, firm pelvic mass; a computed tomography-guided biopsy confirmed recurrent carcinoma, and staging scans disclosed a pulmonary metastasis.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Tewari KS. Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma. J Clin Oncol. 2019. PMID: 31026210. doi:10.1200/JCO.19.00119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。